Skip to main content
Year archive

Alkem Laboratories Limited — 2022 filings

All 199 regulatory filings released by Alkem Laboratories Limited (ALKEM) in 2022, sourced directly from the official regulator.

199 Filings
2022 Period
2022 filings (199)
Filing Released Lang
Pursuant to Regulation 30 of the SEBI Listing Regulations, we hereby wish to inform you that the Company has entered into a Securities Subscription Agreement and Shareholders' Agreement ....
Regulatory Filings
2022-12-23 English
Acquisition
Capital/Financing Update
2022-12-23 English
Trading Window
Regulatory Filings
2022-12-23 English
This is to inform you that in terms of Company's Code of Conduct for Regulating, Monitoring and Reporting of Trading by Insiders, the trading window will remain closed from 30th December, ....
Regulatory Filings
2022-12-23 English
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, attached herewith is the details of Analyst/ Institutional Investor meeting ....
Regulatory Filings
2022-12-22 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2022-12-22 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings
2022-12-16 English
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, attached herewith are the details of Analyst/ Institutional Investor meetings ....
Regulatory Filings
2022-12-16 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings
2022-12-12 English
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, attached herewith is the details of Analyst/ Institutional Investor meeting ....
Regulatory Filings
2022-12-12 English
Newspaper Advertisements
Declaration of Voting Results & Voting Rights Announcements
2022-12-07 English
Pursuant to Regulation 30 and 47 read alongwith Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("the Regulation"), please find enclosed herewith ....
Regulatory Filings
2022-12-07 English
Postal Ballot
Proxy Solicitation & Information Statement
2022-12-06 English
In furtherance to our intimation dated 11.11.2022, this is to inform you that pursuant to the provisions of Section 110 and other applicable provisions, if any, of the Companies Act, 2013 ....
Regulatory Filings
2022-12-06 English
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, attached herewith is the details of Analyst/ Institutional Investor meeting ....
Regulatory Filings
2022-12-02 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings
2022-12-02 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings
2022-11-29 English
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, attached herewith are the details of Analyst/ Institutional Investor meetings ....
Regulatory Filings
2022-11-29 English
Related Party Transaction
Regulatory Filings
2022-11-25 English
Pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed disclosure on a consolidated basis, for the half year ....
Regulatory Filings
2022-11-25 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings
2022-11-23 English
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, attached herewith are the details of Analyst/ Institutional Investor meetings ....
Regulatory Filings
2022-11-23 English
We enclose herewith the transcript of the 'Q2 FY2023 Earnings Conference Call' which was hosted by the Company on Friday, 11th November, 2022. The said transcript shall also be made ....
Regulatory Filings
2022-11-14 English
Transcript of Analysts/Institutional Investor Meet/Con. Call
Call Transcript
2022-11-14 English
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of the 'Q2FY23 Earnings Conference Call' is available ....
Regulatory Filings
2022-11-11 English
Recording of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings
2022-11-11 English
Closure of trading window
Regulatory Filings
2022-11-11 English
General updates
Declaration of Voting Results & Voting Rights Announcements
2022-11-11 English
We refer to our earlier communication dated 28th September, 2022 regarding closure of trading window (for the purpose of financial results for the quarter ended 30th September, 2022) starting ....
Regulatory Filings
2022-11-11 English
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith press release and analyst presentation on Q2FY23 earnings ....
Regulatory Filings
2022-11-11 English
Investor Presentation
Interim / Quarterly Report
2022-11-11 English
This is to inform you that pursuant to the provisions of Section 110 and other applicable provisions, if any, of the Companies Act, 2013 read with Rule 20 and 22 of the Companies (Management ....
Regulatory Filings
2022-11-11 English
Re-appointment
Regulatory Filings
2022-11-11 English
The Board of Directors at its meeting held today, i.e. 11th November, 2022, based on recommendation of Nomination and Remuneration Committee, Audit Committee and subject to the approval ....
Regulatory Filings
2022-11-11 English
In continuation of our letter dated 02nd November, 2022 and pursuant to Regulation 30 read with Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure ....
Regulatory Filings
2022-11-11 English
Outcome of Board Meeting
Regulatory Filings
2022-11-11 English
The Board of Directors at its meeting held today i.e. 11.11.2022 has, inter alia: 1. approved the Standalone and Consolidated Unaudited Financial Results of the Company for the quarter ....
Regulatory Filings
2022-11-11 English
Press Release
Regulatory Filings
2022-11-10 English
This is to inform you that US FDA had conducted a Pre-Approval inspection at the Company's manufacturing facility located at St. Louis, USA from 31st October, 2022 to 09th November, 2022. ....
Regulatory Filings
2022-11-10 English
In continuation of our letter dated 06th October, 2022 and pursuant to provisions of Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this ....
Regulatory Filings
2022-11-07 English
Postal Ballot
Regulatory Filings
2022-11-07 English
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we write to inform you that a conference call to discuss the Q2FY23 financial ....
Regulatory Filings
2022-11-02 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Call Transcript
2022-11-02 English
Alkem Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2022 ,inter alia, to consider and approve the Standalone and Consolidated ....
Regulatory Filings
2022-11-02 English
Board Meeting — Financial results
Regulatory Filings
2022-11-02 English
Newspaper Advertisements
Declaration of Voting Results & Voting Rights Announcements
2022-10-07 English
Pursuant to Regulation 30 and 47 read alongwith Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("the Regulation"), please find enclosed herewith ....
Regulatory Filings
2022-10-07 English
In furtherance to our intimation dated 14.09.2022 this is to inform you that pursuant to the provisions of Section 110 and other applicable provisions, if any, of the Companies Act, 2013 ....
Regulatory Filings
2022-10-06 English
Postal Ballot
Proxy Solicitation & Information Statement
2022-10-06 English
Postal Ballot
Declaration of Voting Results & Voting Rights Announcements
2022-09-29 English
In continuation of our letter dated 29th August, 2022 and pursuant to provisions of Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this ....
Regulatory Filings
2022-09-29 English
Closure of trading window
Regulatory Filings
2022-09-28 English
This is to inform you that in terms of Company's Code of Conduct for Regulating, Monitoring and Reporting of Trading by Insiders, the trading window will remain closed from 29th September, ....
Regulatory Filings
2022-09-28 English
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, attached herewith are the details of Analyst/ Institutional Investor meetings ....
Regulatory Filings
2022-09-27 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings
2022-09-27 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings
2022-09-22 English
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, attached herewith are the details of Analyst/ Institutional Investor/ ....
Regulatory Filings
2022-09-22 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Capital/Financing Update
2022-09-16 English
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, attached herewith are the details of Analyst/ Institutional Investor/ ....
Regulatory Filings
2022-09-16 English
Press Release
Regulatory Filings
2022-09-15 English
This is to inform you that US FDA had conducted a Pre-Approval inspection at the Company's manufacturing facility located at St. Louis, USA from 06th September, 2022 to 14th September, ....
Regulatory Filings
2022-09-15 English
General updates
Declaration of Voting Results & Voting Rights Announcements
2022-09-14 English
This is to inform you that pursuant to the provisions of Section 110 and other applicable provisions, if any, of the Companies Act, 2013 read with Rule 20 and 22 of the Companies (Management ....
Regulatory Filings
2022-09-14 English
Appointment
Board/Management Information
2022-09-14 English
We wish to inform you that the Board of Directors ('Board') of Alkem Laboratories Limited (the 'Company'), at its meeting held today, i.e. on 14th September, 2022 has appointed ....
Regulatory Filings
2022-09-14 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings
2022-09-09 English
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, attached herewith are the details of Analyst/ Institutional Investor/ ....
Regulatory Filings
2022-09-09 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings
2022-09-06 English
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, attached herewith are the details of Analyst/ Institutional Investor/ ....
Regulatory Filings
2022-09-06 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings
2022-09-05 English
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, attached herewith are the details of Analyst/ Institutional Investor meeting ....
Regulatory Filings
2022-09-05 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings
2022-09-01 English
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, attached herewith are the details of Analyst/Institutional Investor meeting ....
Regulatory Filings
2022-09-01 English
Pursuant to Regulation 30 and 47 read alongwith Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("the Regulation"), please find enclosed herewith ....
Regulatory Filings
2022-08-30 English
Newspaper Advertisements
Regulatory Filings
2022-08-30 English
In furtherance to our intimation dated 05.08.2022, this is to inform you that pursuant to the provisions of Sec 110 and other applicable provisions, if any, of the Companies Act, 2013 read ....
Regulatory Filings
2022-08-29 English
Postal Ballot
Regulatory Filings
2022-08-29 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings
2022-08-29 English
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, attached herewith are the details of Analyst/ Institutional Investor meeting ....
Regulatory Filings
2022-08-29 English
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, attached herewith are the details of Analyst/ Institutional Investor/ ....
Regulatory Filings
2022-08-26 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings
2022-08-26 English
This is with reference to the 48th Annual General Meeting (''AGM'') of the Company held on Thursday, 25th August, 2022 at 11.00 a.m. through Video Conferencing (VC)/ Other Audio Visual ....
Regulatory Filings
2022-08-25 English
This is with reference to the 48th Annual General Meeting (''AGM'') of the Company held on Thursday, 25th August, 2022 at 11.00 a.m. through Video Conferencing (VC)/ Other Audio Visual ....
Regulatory Filings
2022-08-25 English
Annual General Meeting
Regulatory Filings
2022-08-25 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings
2022-08-25 English
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, attached herewith are the details of Analyst/ Institutional Investor meetings ....
Regulatory Filings
2022-08-25 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings
2022-08-23 English
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, kindly find attached herewith the details of Analyst/ Institutional Investor/ ....
Regulatory Filings
2022-08-23 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings
2022-08-22 English
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the details of Analyst/ Institutional Investor/ ....
Regulatory Filings
2022-08-22 English
Newspaper Advertisements
Regulatory Filings
2022-08-19 English
Pursuant to Regulation 47 of the Securities & Exchange Board of India (Listing Obligation & Disclosure Requirements) Regulations, 2015, we enclose a copy of the newspaper clipping of Notice ....
Regulatory Filings
2022-08-19 English
Retirement
Board/Management Information
2022-08-18 English
Pursuant to Regulation 30(2) read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that ....
Regulatory Filings
2022-08-18 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Investor Presentation
2022-08-17 English
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached schedule of Analyst/Institutional Investor meeting ....
Regulatory Filings
2022-08-17 English
Transcript of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings
2022-08-10 English
We enclose herewith the transcript of the "Q1 FY2023 Earnings Conference Call" which was hosted by the Company on Friday, 05th August, 2022. The said transcript shall also be made available ....
Regulatory Filings
2022-08-10 English
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of the 'Q1FY23 Earnings Conference Call' is available ....
Regulatory Filings
2022-08-06 English
Recording of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings
2022-08-06 English
Please find attached herewith the revised disclosure for appointment of Mr. Sujjain Talwar (DIN: 01756539) as an Additional Director, designated as an Independent Director on the Board ....
Regulatory Filings
2022-08-05 English
Closure of trading window
Regulatory Filings
2022-08-05 English
General updates
Regulatory Filings
2022-08-05 English
Investor Presentation
Regulatory Filings
2022-08-05 English
We refer to our earlier communication dated 28th June, 2022 regarding closure of trading window (for the purpose of financial results for the quarter ended 30th June, 2022) starting from ....
Regulatory Filings
2022-08-05 English
Appointment
Board/Management Information
2022-08-05 English
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith press release and analyst presentation on Q1FY23 earnings ....
Regulatory Filings
2022-08-05 English
This is to inform you that pursuant to the provisions of Section 110 and other applicable provisions, if any, of the Companies Act, 2013 read with Rule 20 and 22 of the Companies (Management ....
Regulatory Filings
2022-08-05 English
The Board of Directors at its meeting held today, i.e. 05th August, 2022, based on the recommendation of Nomination & Remuneration Committee and subject to approval of shareholders, approved ....
Regulatory Filings
2022-08-05 English
Outcome of Board Meeting
Interim / Quarterly Report
2022-08-05 English
In continuation of our letter dated 25th July, 2022 and pursuant to Regulation 30 read with Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure ....
Regulatory Filings
2022-08-05 English
The Board of Directors of the Company, at its meeting held today, i.e. 05.08.2022 have inter alia: 1. approved the Standalone and Consolidated Unaudited Financial Results for the ....
Regulatory Filings
2022-08-05 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Call Transcript
2022-07-26 English
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we write to inform you that a conference call to discuss the Q1FY23 financial ....
Regulatory Filings
2022-07-26 English
Alkem Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2022 ,inter alia, to consider and approve the Standalone and Consolidated ....
Regulatory Filings
2022-07-25 English
Board Meeting — Financial results
Regulatory Filings
2022-07-25 English
Newspaper Advertisements
Report Publication Announcement
2022-07-12 English
Pursuant to Regulation 30 and 47 read alongwith Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("the Regulation"), please find enclosed herewith ....
Regulatory Filings
2022-07-12 English
Resignation
Board/Management Information
2022-07-11 English
Pursuant to Regulation 30(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Mr. Ranjal Laxmana Shenoy (DIN 00074761) has ....
Regulatory Filings
2022-07-11 English
Please find enclosed herewith the Notice of the 48th Annual General Meeting of the Company scheduled to be held on Thursday, 25th August, 2022 at 11.00 a.m. through Video Conferencing (VC)/ ....
Regulatory Filings
2022-07-11 English
Press Release
Regulatory Filings
2022-07-07 English
This is to inform you that US FDA had conducted a GMP and Pre-Approval inspection at the Company's manufacturing facility located at Indore from 01st July, 2022 to 07th July, 2022. At the ....
Regulatory Filings
2022-07-07 English
Pursuant to Regulation 30 and 47 read along with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("the Regulation"), please find enclosed herewith ....
Regulatory Filings
2022-06-29 English
Newspaper Advertisements
Regulatory Filings
2022-06-29 English
Closure of trading window
Regulatory Filings
2022-06-28 English
This is to inform you that in terms of Company's Code of Conduct for Regulating, Monitoring and Reporting of Trading by Insiders, the trading window will remain closed from 29th June, 2022 ....
Regulatory Filings
2022-06-28 English
This is to inform you that US FDA had conducted an inspection of the Company's manufacturing facility located at St. Louis, USA from 06th June, 2022 to 17th June, 2022. At the end of ....
Regulatory Filings
2022-06-18 English
Press Release
Regulatory Filings
2022-06-18 English
Related Party Transaction
Regulatory Filings
2022-05-25 English
Pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed disclosures of related party transactions, on a consolidated ....
Regulatory Filings
2022-05-25 English
In terms of Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith Annual Secretarial Compliance Report for the period ....
Regulatory Filings
2022-05-23 English
Transcript of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings
2022-05-16 English
We enclose herewith the transcript of the 'Q4 FY2022 Earnings Conference Call' which was hosted by the Company on Friday, 13th May, 2022. The said transcript shall also be made available ....
Regulatory Filings
2022-05-16 English
Recording of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings
2022-05-13 English
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of the 'Q4FY22 and FY22 Earnings Conference Call' ....
Regulatory Filings
2022-05-13 English
Press Release
Regulatory Filings
2022-05-13 English
This is to inform you that MHRA had conducted an online inspection at the Company's Bioequivalence Center located at Taloja, Maharashtra from 31st January, 2022 to 4th February, 2022 and ....
Regulatory Filings
2022-05-13 English
Closure of trading window
Regulatory Filings
2022-05-13 English
Re-appointment
Regulatory Filings
2022-05-13 English
Investor Presentation
Regulatory Filings
2022-05-13 English
The Board of Directors at its meeting held today i.e. 13th May, 2022, has, inter alia based on recommendation of Nomination and Remuneration Committee, Audit Committee and subject to approval ....
Regulatory Filings
2022-05-13 English
We refer to our earlier communication dated 28th March, 2022 regarding closure of trading window (for the purpose of financial results for the quarter and year ended 31st March, 2022) starting ....
Regulatory Filings
2022-05-13 English
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith press release and analyst presentation on Q4FY22 and ....
Regulatory Filings
2022-05-13 English
General updates
Board/Management Information
2022-05-13 English
The Board of Directors at its meeting held today i.e. 13th May, 2022, has, inter alia fixed 10th August, 2022 as the record date for the payment of final dividend and 18th August, 2022 ....
Regulatory Filings
2022-05-13 English
The Board of Directors at its meeting held today i.e. 13th May, 2022, has, inter alia: 1. recommended a final dividend of Rs. 4/- per equity share of Rs. 2/- each for the financial year ....
Regulatory Filings
2022-05-13 English
Record Date
Regulatory Filings
2022-05-13 English
In continuation of our letter dated 28th April, 2022 and pursuant to Regulation 30 read with Regulation 33 of the SEBI LODR (''Listing Regulations'') the Board of Directors of the Company, ....
Regulatory Filings
2022-05-13 English
Financial Result Updates
Regulatory Filings
2022-05-13 English
Please find enclosed the outcome of the BM dated 13.5.22
Regulatory Filings
2022-05-13 English
Dividend
Regulatory Filings
2022-05-13 English
Outcome of Board Meeting
Regulatory Filings
2022-05-13 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings
2022-05-02 English
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we write to inform you that a conference call to discuss the Q4FY22 and FY22 ....
Regulatory Filings
2022-05-02 English
Alkem Laboratories Ltd has informed BSE that a meeting of the Board of Directors of the Company is scheduled to be held on May 13, 2022, inter alia:1. To consider and approve the ....
Regulatory Filings
2022-04-28 English
Alkem Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/05/2022 ,inter alia, to consider and approve (i) to consider and approve ....
Regulatory Filings
2022-04-28 English
Board Meeting — Dividend/Financial results
Regulatory Filings
2022-04-28 English
Press Release
Regulatory Filings
2022-04-14 English
This is to inform you that US FDA had conducted an inspection at the Company's Bioequivalence Center located at Taloja, Maharashtra from 11th April, 2022 to 14th April, 2022. At the ....
Regulatory Filings
2022-04-14 English
In terms of Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith Certificate received from Practising Company Secretary ....
Regulatory Filings
2022-04-13 English
Press Release
Regulatory Filings
2022-04-13 English
This is to inform you that ISP Chile had conducted a GMP inspection at the Company's manufacturing facility located at Baddi, India from 06th April, 2022 to 12th April, 2022. At the ....
Regulatory Filings
2022-04-13 English
With reference to the subject matter, please find enclosed herewith the Compliance Certificate under Regulation 7(3) SEBI (Listing Obligations and Disclosure Requirements) Regulations, ....
Regulatory Filings
2022-04-11 English
This is to inform you that ISP Chile had conducted an inspection at the Company's manufacturing facility located at Daman, India from 28th March, 2022 to 01st April, 2022. At the end ....
Regulatory Filings
2022-04-01 English
Press Release
Regulatory Filings
2022-04-01 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings
2022-04-01 English
Closure of trading window
Regulatory Filings
2022-03-28 English
This is to inform you that in terms of Company's Code of Conduct for Regulating, Monitoring and Reporting of Trading by Insiders, the trading window will remain closed from 30th March, ....
Regulatory Filings
2022-03-28 English
In continuation of our letter dated 11th January, 2022 and pursuant to provisions of Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this ....
Regulatory Filings
2022-02-11 English
Shareholders meeting
Regulatory Filings
2022-02-11 English
Press Release
Regulatory Filings
2022-02-11 English
This is to intimate you that Alkem Laboratories Limited (the 'Company') and Harvard University's Office of Technology Department (OTD) have signed a license agreement for the development ....
Regulatory Filings
2022-02-11 English
Please find enclosed herewith the transcript of the 'Q3 FY2022 Earnings Conference Call' which was hosted by the Company on Friday, 04th February, 2022. The said transcript shall also ....
Regulatory Filings
2022-02-09 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2022-02-09 English
Trading Window
Regulatory Filings
2022-02-04 English
We refer to our earlier communication dated 21st December, 2021 regarding closure of trading window (for the purpose of financial results for the quarter ended 31st December, 2021) starting ....
Regulatory Filings
2022-02-04 English
Investor Presentation
Regulatory Filings
2022-02-04 English
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith press release and analyst presentation on Q3FY22 and ....
Regulatory Filings
2022-02-04 English
Record Date
Regulatory Filings
2022-02-04 English
In continuation of our letter dated 24th January, 2022 the Board of Directors of the Company, at its meeting held today, i.e. 04th February, 2022 inter alia, has declared Interim Dividend ....
Regulatory Filings
2022-02-04 English
In continuation of our letter dated 24th January, 2022 and pursuant to Regulation 30 read with Regulation 33 and Regulation 42 of the Securities and Exchange Board of India (Listing Obligations ....
Regulatory Filings
2022-02-04 English
Financial Result Updates
Regulatory Filings
2022-02-04 English
Dividend
Regulatory Filings
2022-02-04 English
Outcome of Board Meeting
Regulatory Filings
2022-02-04 English
The Board of Directors of the Company, at its meeting held today, i.e. 04th February, 2022 have inter alia: a. Approved the Standalone and Consolidated Unaudited Financial Results ....
Regulatory Filings
2022-02-04 English
This is to intimate you that Alkem Laboratories Limited (the 'Company') and Johns Hopkins University, on behalf of its School of Medicine (JHU) have entered into an exclusive license agreement ....
Regulatory Filings
2022-01-31 English
Press Release
Regulatory Filings
2022-01-31 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2022-01-25 English
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we write to inform you that a conference call to discuss the Q3FY22 and 9MFY22 ....
Regulatory Filings
2022-01-25 English
The record date for the purpose of payment of Interim Dividend for the Financial Year 2021-2022, would be Saturday, 12th February, 2022, subject to declaration of the said Interim Dividend ....
Regulatory Filings
2022-01-24 English
Record Date
Regulatory Filings
2022-01-24 English
The record date for the purpose of payment of Interim Dividend for the Financial Year 2021-2022, would be Saturday, 12th February, 2022, subject to declaration of the said Interim Dividend ....
Regulatory Filings
2022-01-24 English
Board Meeting — Financial Results/Dividend
Regulatory Filings
2022-01-24 English
Alkem Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/02/2022 ,inter alia, to consider and approve (i) the Standalone and Consolidated ...
Regulatory Filings
2022-01-24 English
Pursuant to Regulation 30 and 47 read alongwith Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("the Regulation"), please find enclosed herewith ....
Regulatory Filings
2022-01-12 English
Copy of Newspaper Publication
Regulatory Filings
2022-01-12 English
In furtherance to our intimation dated 20.12.2021, this is to inform you that pursuant to the provisions of Section 110 and other applicable provisions, if any, of the Companies Act, 2013 ....
Regulatory Filings
2022-01-11 English
Shareholders meeting
Proxy Solicitation & Information Statement
2022-01-11 English